Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Caplin Point Laboratories Limited

Market Cap 19TCr 199.98Cr 175.68Cr 161.88Cr 151.54Cr 283.92Cr 288.71Cr 1.94TCr 752.41Cr 9.29TCr 750.71Cr 734.55Cr 32TCr P/E 2026
17.9x
P/E 2027 * 26.6x
Enterprise Value 19TCr 199.98Cr 175.68Cr 161.88Cr 151.54Cr 283.92Cr 288.71Cr 1.94TCr 752.41Cr 9.29TCr 750.71Cr 734.55Cr 32TCr EV / Sales 2026
5.23x
EV / Sales 2027 * 7.61x
Free-Float
26.39%
Yield 2026 *
-
Yield 2027 * 0.16%
1 day+3.34%
1 week+10.25%
Current month+27.15%
1 month+23.88%
3 months+62.28%
6 months+30.66%
Current year+40.05%
1 week 2,338.8
Extreme 2338.8
2,590
1 month 1,950
Extreme 1950
2,590
Current year 1,500.3
Extreme 1500.3
2,590
1 year 1,500.3
Extreme 1500.3
2,590
3 years 783.05
Extreme 783.05
2,641
5 years 575
Extreme 575
2,641
10 years 176.2
Extreme 176.2
2,641
Manager TitleAgeSince
Chief Executive Officer 71 28/03/2015
Director of Finance/CFO - 19/02/2016
Chief Administrative Officer - -
Director TitleAgeSince
Chairman 73 27/01/2010
Director/Board Member - 05/11/2025
Director/Board Member 71 28/03/2015
Change 5-day change 1-year change 3-year change Capi.($)
+3.26%+10.25% - - 203.89Cr
+0.43%+3.05%+12.89%+88.54% 4.73TCr
+1.54%+2.93%+53.78%+102.19% 3.46TCr
+0.08%+6.20%-4.51%+40.39% 1.21TCr
+0.76%+5.71%+16.32%+99.72% 1.16TCr
-0.57%-0.57%+37.80%+122.46% 901.55Cr
+0.59%+0.17%+16.96%+41.10% 702.4Cr
+1.05%+4.62%+50.72%-12.83% 682.84Cr
+0.43%+2.61%+30.26%+239.70% 654.55Cr
+0.71%+2.14%-35.63%+0.19% 506.59Cr
Average +0.87%+1.69%+19.84%+80.16% 1.56TCr
Weighted average by Cap. +0.75%+2.46%+24.48%+87.41%

Financials

2026 2027 *
Net sales 2.13TCr 22Cr 20Cr 18Cr 17Cr 32Cr 32Cr 218.34Cr 85Cr 1.04TCr 84Cr 83Cr 3.63TCr 2.49TCr 26Cr 23Cr 21Cr 20Cr 37Cr 38Cr 255.28Cr 99Cr 1.22TCr 99Cr 96Cr 4.24TCr
Net income 616.2Cr 6.5Cr 5.71Cr 5.27Cr 4.93Cr 9.24Cr 9.39Cr 63Cr 24Cr 302.34Cr 24Cr 24Cr 1.05TCr 712.75Cr 7.52Cr 6.61Cr 6.09Cr 5.7Cr 11Cr 11Cr 73Cr 28Cr 349.71Cr 28Cr 28Cr 1.22TCr
Net Debt - -
Logo Caplin Point Laboratories Limited
Caplin Point Laboratories Limited is an India-based pharmaceutical company with a business model catering predominantly to emerging markets of Latin America and Africa. The Company has also entered regulated markets such as the United States through its Subsidiary, Caplin Steriles Limited. The Company's operations include research & development and manufacturing of finished formulations, active pharmaceutical ingredients (APIs), clinical research, front-end generic presence in Latin America, brand marketing in Francophone Africa and a USFDA/EU-GMP approved injectable facility. In the Regulated Markets, its products include liquid & lyophilized vials, pre-filled syringes, three-pc ophthalmic droppers and pre-mix bags. In the Emerging Markets, its products include tablets, dry syrups - bottles, soft gels, capsules, suppositories, liquid syrups - bottles, liquid injectables in ampoules & vials, lyophilized vials, prefilled syringes (PFS), and emulsion injection in ampoules & vials.
Employees
3,966
Date Price Change Volume
24/26/24 2,572.00 +3.26% 33,491
23/26/23 ₹2,490.90 -1.83% 1,27,384
22/26/22 ₹2,537.40 +1.35% 1,57,503
19/26/19 ₹2,503.50 +6.11% 4,02,481
18/26/18 ₹2,359.40 +1.05% 56,125
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2,492.20INR
Average target price
2,505.00INR
Spread / Average Target
+0.51%

Quarterly revenue - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!